Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Number of holders
-
92
-
Total 13F shares, excl. options
-
8,789,399
-
Shares change
-
+384,868
-
Total reported value, excl. options
-
$715,910,314
-
Value change
-
+$32,118,674
-
Put/Call ratio
-
114%
-
Number of buys
-
58
-
Number of sells
-
-31
-
Price
-
$82.33
Significant Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q2 2014
102 filings reported holding FBT - FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH as of Q2 2014.
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) has 92 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8,789,399 shares
.
Largest 10 shareholders include MORGAN STANLEY (2,105,889 shares), WELLS FARGO & COMPANY/MN (1,557,136 shares), FIRST TRUST ADVISORS LP (876,359 shares), UBS AG (687,611 shares), BANK OF AMERICA CORP /DE/ (631,179 shares), RiverFront Investment Group, LLC (403,381 shares), RAYMOND JAMES & ASSOCIATES (338,379 shares), GOLDMAN SACHS GROUP INC (310,142 shares), LPL Financial LLC (214,656 shares), and ROYAL BANK OF CANADA (157,239 shares).
This table shows the top 92 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.